Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis

Serum neurofilament light chain (NfL) is emerging as an important biomarker in multiple sclerosis (MS). Our objective was to evaluate the prognostic value of serum NfL levels obtained close to the time of MS onset with long-term clinical outcomes. In this prospective cohort study, we identified pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Thebault, Simon, Abdoli, Mohammad, Fereshtehnejad, Seyed-Mohammad, Tessier, Daniel, Tabard-Cossa, Vincent, Freedman, Mark S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316736/
https://www.ncbi.nlm.nih.gov/pubmed/32587320
http://dx.doi.org/10.1038/s41598-020-67504-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7316736/
https://www.ncbi.nlm.nih.gov/pubmed/32587320
http://dx.doi.org/10.1038/s41598-020-67504-6

Ejemplares similares